deconex ir

Generic: guaifenesin and phenylephrine hcl

Labeler: poly pharmaceuticals, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name deconex ir
Generic Name guaifenesin and phenylephrine hcl
Labeler poly pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

guaifenesin 385 mg/1, phenylephrine hydrochloride 10 mg/1

Manufacturer
Poly Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 50991-736
Product ID 50991-736_1cda79a6-71f0-4793-e063-6394a90a9a8a
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2016-08-08

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50991736
Hyphenated Format 50991-736

Supplemental Identifiers

RxCUI
1805155
UNII
495W7451VQ 04JA59TNSJ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deconex ir (source: ndc)
Generic Name guaifenesin and phenylephrine hcl (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 385 mg/1
  • 10 mg/1
source: ndc
Packaging
  • 12 BLISTER PACK in 1 CARTON (50991-736-02) / 2 TABLET in 1 BLISTER PACK
  • 1 BOTTLE in 1 CARTON (50991-736-90) / 90 TABLET in 1 BOTTLE
source: ndc

Packages (2)

50991-736-02 12 BLISTER PACK in 1 CARTON (50991-736-02) / 2 TABLET in 1 BLISTER PACK 50991-736-90 1 BOTTLE in 1 CARTON (50991-736-90) / 90 TABLET in 1 BOTTLE

Ingredients (2)

guaifenesin (385 mg/1) phenylephrine hydrochloride (10 mg/1)

Linked Drug Pages (1)

Deconex IR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1cda79a6-71f0-4793-e063-6394a90a9a8a", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "04JA59TNSJ"], "rxcui": ["1805155"], "spl_set_id": ["4710095e-3dae-4a39-8a98-873012e1f003"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Poly Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BLISTER PACK in 1 CARTON (50991-736-02)  / 2 TABLET in 1 BLISTER PACK", "package_ndc": "50991-736-02", "marketing_start_date": "20160808"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (50991-736-90)  / 90 TABLET in 1 BOTTLE", "package_ndc": "50991-736-90", "marketing_start_date": "20160808"}], "brand_name": "Deconex IR", "product_id": "50991-736_1cda79a6-71f0-4793-e063-6394a90a9a8a", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "50991-736", "generic_name": "Guaifenesin and Phenylephrine HCl", "labeler_name": "Poly Pharmaceuticals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Deconex IR", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "385 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20160808", "listing_expiration_date": "20261231"}